CASPER, Wyo. — Johnson & Johnson is voluntary recalling some baby powder after a sample revealed “chrysotile fibers, a type of asbestos.”
The United States Food and Drug Administration alerted consumers on Friday, Oct. 18.
“Consumers who have Johnson’s Baby Powder lot #22318RB should stop using it immediately and contact Johnson & Johnson for a refund,” the FDA said. “The FDA stands by the quality of its testing and results and is not aware of any adverse events relating to exposure to the lot of affected products.”
Article continues below...
They add that the talc can be contaminated with asbestos if talc ore is not purified carefully or if poor talc mining sites are chosen.
“Asbestos is a known carcinogen,” the FDA adds. “It is important to note that the FDA has been conducting testing of talc-containing cosmetic products for asbestos. Not all talc contains asbestos and the majority of product samples tested by the FDA did not contain asbestos.”
The FDA says they have tested about 50 cosmetic products for asbestos since 2018.
“As part of this testing, two samples of Johnson’s Baby Powder were tested: one sample from lot #22318RB was found to be positive for asbestos; a second Johnson’s Baby Powder sample, lot #00918RA, tested negative for asbestos,” they say.
“The FDA expects to issue the full results from this survey, including all tested products having both positive and negative results, by the end of the year. Since undertaking the testing, the agency has warned consumers when products tested positive for asbestos, advising them to stop using affected products, including not to use certain products from Claire’s and Beauty Plus Global. The FDA will continue to update its safety alert with new information as it becomes available.”
Cosmetic products and ingredients besides color additives don’t require FDA review before going to market.
“Although the FDA doesn’t have pre-market review authority, the agency has the responsibility to monitor the cosmetics market and can take appropriate action to protect consumers in the post-market setting,” they say. “Cosmetics must not be ‘adulterated’ or ‘misbranded,’ meaning they must be safe for consumers when used according to directions on the label, or in the customary or expected way, and they must be properly labeled. The agency is again calling on industry to register and list their products via the FDA’s Voluntary Cosmetics Registration Program although under current law, registration and listing are not required.”